Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-05 Sale |
2025-06-06 4:47 pm |
Kronos Bio Inc. | KRON | KNOBELMAN DEBORAH President & Interim CEO |
24,838 | $0.8678 | $21,554 | 139,422 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-03 Option Award |
2024-06-04 5:02 pm |
N/A 2034-06-02 |
Kronos Bio Inc. | KRON | KNOBELMAN DEBORAH Chief Financial Officer |
410,650 | $0 | 410,650 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 5:24 pm |
N/A 2034-01-31 |
Senti Biosciences Inc. | SNTI | KNOBELMAN DEBORAH Chief Financial Officer |
253,000 | $0 | 283,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:20 pm |
N/A 2033-01-31 |
Senti Biosciences Inc. | SNTI | KNOBELMAN DEBORAH Chief Financial Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-04 4:47 pm |
N/A 2032-10-02 |
Senti Biosciences Inc. | SNTI | KNOBELMAN DEBORAH Chief Financial Officer |
270,000 | $0 | 270,000 (Direct) |
View |
Ownership |
2022-06-15 6:00 pm |
N/A 2031-05-19 |
Senti Biosciences Inc. | SNTI | KNOBELMAN DEBORAH Chief Financial Officer |
0 | $0 | 1,094,483 (Direct) |
View |